With True Bone Regeneration

Developed by a dentist, for dentists, EthOss helps patients grow back their bone fast, with no graft particles left behind.

It goes beyond GBR, working with the body’s healing response by using next-generation alloplast and synthetic biomaterials. Based on 3 decades of implantology expertise, all aspects of the product – particle shape and stacking, porosity and surface area – have gone through rigorous development to provide the powerful, predictable results you need.

Ethoss' innovative approach is a step forward in several ways:

Its built-in calcium sulphate binder helps stabilise the graft and prevent soft tissue ingress, eliminating the need for an added collagen membrane.

EthOss is 100% synthetic. There’s no human or animal content, so no risk of cross-contamination.

EthOss comes in a handy syringe applicator, in two sizes – 0.5cc and 1cc. It’s easy to mix and quick to apply. And because it keeps its volume well, there’s no need for over-packing.

EthOss is fully absorbed into the body, as it’s replaced by new healthy host bone – up to 50% in as little as 12 weeks.

Clinical Applications

  • > Guided Bone Regeneration (GBR)

  • > Buccal defects

  • > Sinus lifts

  • > Socket grafts

  • > Periodontitis

  • > Peri-implantitis

Tech Specs

Composition 65% beta tricalcium phosphate, (βTCP) Ca3(PO4)2, 35% calcium sulfate CaSO4
Volumetric Porosity 50% - 70%
BTCP Pore Size 400μm
BTCP Particle Size 0.1mm - 0.5mm
BTCP Mechanical Resistance 3,0 MPa
Resorption Time Typically 50% new bone at 12 weeks. Full resorption usually over following 6-12 months.
Volumes Available 0.5cc, 1cc
Mixing Agent Standard sterile saline (0.9% Sodium Chloride) only
Recommended Re-Entry Time 12 weeks

Proven Results


A piece of tissue composed of both compact and trabecular woven bone within moderately cellular fibroblastic tissue. Both active fibroplasia and osseous production are underway. Multiple, variably sized ‘cavities’ containing residual refractile granular graft material are present throughout the sample.

Approximately 50% (overall) is induced woven bone. No pre-existing host lamellar bone is present. No significant inflammatory cell infiltrate is present.